[1] |
CAO Xiaoshan, YANG Beibei, CONG Binbin, LIU Hong.
The progress of treatment for brain metastases of triple-negative breast cancer
[J]. China Oncology, 2024, 34(8): 777-784.
|
[2] |
WU Zhibai, XU Guiqin, ZHANG Li, YANG Zhaojuan, LIU Yun, JIAO Kun, CHEN Zehong, XU Chen, ZUO You, ZHENG Ningqian, YE Zhiqian, LIU Yongzhong.
Mechanism study of KCMF1 promoting proliferation and NF-κB signaling transduction in colorectal cancer cells
[J]. China Oncology, 2024, 34(11): 987-997.
|
[3] |
XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou.
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
[J]. China Oncology, 2024, 34(11): 998-1010.
|
[4] |
CHEN Junyao, ZHANG Wentao, LIU Qiao, NIE Jianyun.
Clinical dilemma and systemic treatment strategy of triple-negative breast cancer in the elderly
[J]. China Oncology, 2023, 33(5): 506-516.
|
[5] |
SHAO Zhibo, YANG Benlong, WU Jiong.
Progress of important clinical trials of breast cancer in China in 2022
[J]. China Oncology, 2023, 33(2): 103-109.
|
[6] |
XIAO Yuling, ZHU Xiuzhi, JIANG Yizhou, SHAO Zhimin.
New research advances and future prospect in precision treatment of triple-negative breast cancer
[J]. China Oncology, 2022, 32(8): 669-679.
|
[7] |
PANG Yi, WU Chunxiao, GU Kai, BAO Pingping, WANG Chunfang, SHI Liang, GONG Yangming, XIANG Yongmei, DOU Jianming, WU Mengyin, FU Chen, SHI Yan.
Analysis of current status of cervical cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016
[J]. China Oncology, 2022, 32(6): 519-526.
|
[8] |
DUAN Yuqing, XIA Ning, JIA Yunlong, ZHENG Wenya, LIU Lihua.
SRSF1 promotes proliferation, invasion and migration of esophageal squamous cell carcinoma Eca9706 cells by regulating VEGFA mRNA alternative splicing
[J]. China Oncology, 2022, 32(3): 191-199.
|
[9] |
TANG Bo, ZHAO Xia, LIU Hongbing, ZHANG Qingfeng, LIU Kui.
Application of end-to-end double-layer hand-sewn esophagogastric anastomosis and gastric fundus embedding during minimally invasive esophagectomy for esophageal cancer
[J]. China Oncology, 2022, 32(3): 251-257.
|
[10] |
WANG Jiahui, JIANG Linlan, SHEN Zan.
New progress and prospect of breast cancer bone metastasis research from mechanism to clinic
[J]. China Oncology, 2022, 32(2): 172-176.
|
[11] |
WU Mengyin, WU Chunxiao, PANG Yi, WANG Chunfang, GU Kai, GONG Yangming, BAO Pingping, SHI Liang, DOU Jianming, XIANG Yongmei, SHI Yan.
Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016
[J]. China Oncology, 2022, 32(2): 97-105.
|
[12] |
XIE Jinfang , CAO Chunyu , REN Xue , TIAN Jiajun , LÜ Yafeng , HUANG Xiaofei .
Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells
[J]. China Oncology, 2021, 31(7): 605-615.
|
[13] |
YANG Jia , LIU Shuyuan , WANG Yingying , LI Yingfu , MA Qianli , LI Yu , WANG Yongrong , LI Chuanyin , TAN Fang .
The association of polymorphisms in TNF-α gene with non-small cell lung cancer in Han population of Yunnan Province
[J]. China Oncology, 2021, 31(7): 616-628.
|
[14] |
ZHANG Jian , SHEN Weina , JI Dongmei , WANG Leiping , GONG Chengcheng , HU Xichun .
FUSCC criteria for the management of targeted drug-induced interstitial lung disease in solid tumors
[J]. China Oncology, 2021, 31(4): 241-249.
|
[15] |
LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang .
Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
[J]. China Oncology, 2021, 31(4): 350-360.
|